VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
62 hedge funds and large institutions have $44.1M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 24 reducing their positions, and 17 closing their positions.
Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
9
Reduced
24
Closed
17
Calls
$716K
Puts
$226K
Net Calls
+$490K
Net Calls Change
-$157K
Top Buyers
1 |
LCM
1
Laurion Capital Management
New York
|
$2.71M |
2 |
2
Millennium Management
New York
|
$1.23M |
3 |
MCM
3
MAI Capital Management
Independence,
Ohio
|
$2.51M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$1.82M |
5 |
E
5
Ergoteles
New York
|
$604K |